Loading...

Robert H Weiss, MD

Title(s)Professor, Nephrology
SchoolUniversity of California, Davis
Address6300 GBSF
CA 95616
Phone530-752-4010
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    A Metabolomic Approach to Discovering Markers for ADPKD Progression
    NIH/NIDDK R01DK107416Aug 25, 2016 - May 31, 2019
    Role: Principal Investigator
    The addition of fish oil to sorafenib may prevent kidney cancer metastasis
    NIH/NCI R03CA181837Jan 1, 2014 - Dec 31, 2015
    Role: Principal Investigator
    A Metabolomic Approach to Discovering Biomarkers for ADPKD
    NIH/NIDDK R01DK082690Aug 17, 2009 - Jun 30, 2013
    Role: Principal Investigator
    Metabolomic discovery and validation of urinary biomarkers for kidney cancer
    NIH/NCI R01CA135401Mar 23, 2009 - Jan 31, 2015
    Role: Principal Investigator
    Cyclin Kinase Inhibitors as Molecular Targets for Cancer
    NIH/NCI R21CA091259Apr 1, 2002 - Mar 31, 2004
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance. Sports (Basel). 2020 Apr 01; 8(4). Høeg TB, Chmiel K, Warrick AE, Taylor SL, Weiss RH. PMID: 32244618.
      View in: PubMed   Mentions:
    2. A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells. Sci Rep. 2020 Mar 06; 10(1):4203. Asawa RR, Danchik C, Zahkarov A, Chen Y, Voss T, Jadhav A, Wallace DP, Trott JF, Weiss RH, Simeonov A, Martinez NJ. PMID: 32144367.
      View in: PubMed   Mentions:    Fields:    
    3. The Cell-Cycle Regulatory Protein p21CIP1/WAF1 Is Required for Cytolethal Distending Toxin (Cdt)-Induced Apoptosis. Pathogens. 2020 Jan 02; 9(1). Shenker BJ, Walker LM, Zekavat A, Weiss RH, Boesze-Battaglia K. PMID: 31906446.
      View in: PubMed   Mentions:
    4. Introduction: Why Do We Need a Special Volume on Kidney Cancer? Semin Nephrol. 2020 Jan; 40(1):1. Weiss RH. PMID: 32130961.
      View in: PubMed   Mentions:    Fields:    
    5. Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. Oncogene. 2020 Feb; 39(6):1231-1245. Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R. PMID: 31616061.
      View in: PubMed   Mentions:    Fields:    
    6. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course. BMC Nephrol. 2019 02 25; 20(1):66. Kim K, Trott JF, Gao G, Chapman A, Weiss RH. PMID: 30803434.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma. Signal Transduct Target Ther. 2019; 4:2. Xu J, Chang WH, Fong LWR, Weiss RH, Yu SL, Chen CH. PMID: 30701095.
      View in: PubMed   Mentions:
    8. Translating L-2-HG to kidney cancer at the bench and bedside. Ann Transl Med. 2018 Dec; 6(Suppl 2):S103. Aboud OA, Weiss RH. PMID: 30740424.
      View in: PubMed   Mentions:
    9. Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis. Am J Physiol Renal Physiol. 2018 12 01; 315(6):F1855-F1868. Trott JF, Hwang VJ, Ishimaru T, Chmiel KJ, Zhou JX, Shim K, Stewart BJ, Mahjoub MR, Jen KY, Barupal DK, Li X, Weiss RH. PMID: 30280600.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    10. XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. Oncotarget. 2018 Oct 02; 9(77):34567-34581. Baek HB, Lombard AP, Libertini SJ, Fernandez-Rubio A, Vinall R, Gandour-Edwards R, Nakagawa R, Vidallo K, Nishida K, Siddiqui S, Wettersten H, Landesman Y, Weiss RH, Ghosh PM, Mudryj M. PMID: 30349650.
      View in: PubMed   Mentions:    Fields:    
    11. Management of the Incidental Kidney Mass in the Nephrology Clinic. Clin J Am Soc Nephrol. 2018 09 07; 13(9):1407-1409. Hu SL, Weiss RH. PMID: 29653957.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Metabolomics and Metabolic Reprogramming in Kidney Cancer. Semin Nephrol. 2018 03; 38(2):175-182. Weiss RH. PMID: 29602399.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    13. The role of nephrologists in the management of small renal masses. Nat Rev Nephrol. 2018 04; 14(4):211-212. Hu SL, Weiss RH. PMID: 29398708.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Rho GTPase effectors and NAD metabolism in cancer immune suppression. Expert Opin Ther Targets. 2018 01; 22(1):9-17. Chaker M, Minden A, Chen S, Weiss RH, Chini EN, Mahipal A, Azmi AS. PMID: 29207896.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    15. The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation. Oncotarget. 2017 Dec 26; 8(69):113502-113515. Bianchi C, Meregalli C, Bombelli S, Di Stefano V, Salerno F, Torsello B, De Marco S, Bovo G, Cifola I, Mangano E, Battaglia C, Strada G, Lucarelli G, Weiss RH, Perego RA. PMID: 29371925.
      View in: PubMed   Mentions: 3     Fields:    
    16. Translating Metabolic Reprogramming into New Targets for Kidney Cancer. Kidney Cancer. 2017 Nov 27; 1(2):93-97. Abu Aboud O, Weiss RH. PMID: 30334010.
      View in: PubMed   Mentions:
    17. The Presented Evidence to Support Symptomatic Hypovolemic-Associated EAH Is Not Convincing. Curr Sports Med Rep. 2017 Nov/Dec; 16(6):464-466. Hoffman MD, Weiss RH. PMID: 29135648.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging. Cancer Res. 2017 12 01; 77(23):6746-6758. Abu Aboud O, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ, Sutcliffe J, Weiss RH. PMID: 29021138.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    19. Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease. Kidney Int. 2017 10; 92(4):922-933. Hwang VJ, Zhou X, Chen X, Trott J, Abu Aboud O, Shim K, Dionne LK, Chmiel KJ, Senapedis W, Baloglu E, Mahjoub MR, Li X, Weiss RH. PMID: 28545714.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    20. Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017 07; 13(7):410-419. Wettersten HI, Aboud OA, Lara PN, Weiss RH. PMID: 28480903.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    21. Effects of imputation on correlation: implications for analysis of mass spectrometry data from multiple biological matrices. Brief Bioinform. 2017 03 01; 18(2):312-320. Taylor SL, Ruhaak LR, Kelly K, Weiss RH, Kim K. PMID: 26896791.
      View in: PubMed   Mentions: 7     Fields:    
    22. GHetting to know ADPKD proliferative signaling, STAT. Kidney Int. 2017 03; 91(3):524-526. Chen CH, Weiss RH. PMID: 28202165.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    23. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target. Oncogene. 2017 06 22; 36(25):3588-3598. Chen CH, Fong LWR, Yu E, Wu R, Trott JF, Weiss RH. PMID: 28166200.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    24. Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer. Oncotarget. 2016 10 11; 7(41):66540-66557. Trott JF, Kim J, Abu Aboud O, Wettersten H, Stewart B, Berryhill G, Uzal F, Hovey RC, Chen CH, Anderson K, Graef A, Sarver AL, Modiano JF, Weiss RH. PMID: 27572319.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    25. Metabolomic profiling for early cancer detection: current status and future prospects. Expert Opin Drug Metab Toxicol. 2016 Nov; 12(11):1263-1265. Hwang VJ, Weiss RH. PMID: 27642860.
      View in: PubMed   Mentions: 3     Fields:    
    26. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage. Cell Cycle. 2016 Nov 16; 15(22):3048-3059. Habib SL, Yadav A, Kidane D, Weiss RH, Liang S. PMID: 27611085.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    27. Multivariate two-part statistics for analysis of correlated mass spectrometry data from multiple biological specimens. Bioinformatics. 2017 01 01; 33(1):17-25. Taylor SL, Ruhaak LR, Weiss RH, Kelly K, Kim K. PMID: 27592710.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    28. Does Acute Kidney Injury From an Ultramarathon Increase the Risk for Greater Subsequent Injury? Clin J Sport Med. 2016 Sep; 26(5):417-22. Hoffman MD, Weiss RH. PMID: 26657822.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth. Mol Cancer Ther. 2016 09; 15(9):2119-29. Abu Aboud O, Chen CH, Senapedis W, Baloglu E, Argueta C, Weiss RH. PMID: 27390344.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    30. Extraction and Quantification of Tryptophan and Kynurenine from Cultured Cells and Media Using a High Performance Liquid Chromatography (HPLC) System Equipped with an Ultra-Sensitive Diode Array Detector. Bio Protoc. 2016 Apr 05; 6(7). Kim J, Stewart B, Weiss RH. PMID: 27213172.
      View in: PubMed   Mentions:
    31. The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma. J Am Soc Nephrol. 2016 Aug; 27(8):2227-37. Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH. PMID: 26961346.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    32. Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy. Mol Cancer Ther. 2016 05; 15(5):890-8. Kim J, Ulu A, Wan D, Yang J, Hammock BD, Weiss RH. PMID: 26921392.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    33. Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. AIDS. 2016 Jan; 30(2):171-83. Elahi S, Weiss RH, Merani S. PMID: 26645604.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    34. Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation. PLoS One. 2015; 10(12):e0144996. Berthelot CC, Kamita SG, Sacchi R, Yang J, Nording ML, Georgi K, Hegedus Karbowski C, German JB, Weiss RH, Hogg RJ, Hammock BD, Zivkovic AM. PMID: 26672987.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    35. The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate. Am J Physiol Renal Physiol. 2015 Sep 15; 309(6):F492-8. Hwang VJ, Kim J, Rand A, Yang C, Sturdivant S, Hammock B, Bell PD, Guay-Woodford LM, Weiss RH. PMID: 26155843.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    36. Cancers Best Paper Award 2015. Cancers (Basel). 2015 May 29; 7(2):963-5. Weiss RH. PMID: 26791307.
      View in: PubMed   Mentions:
    37. Spontaneous ?H2AX Foci in Human Solid Tumor-Derived Cell Lines in Relation to p21WAF1 and WIP1 Expression. Int J Mol Sci. 2015 May 20; 16(5):11609-28. Mirzayans R, Andrais B, Scott A, Wang YW, Weiss RH, Murray D. PMID: 26006237.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    38. Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis. Cancer Res. 2015 Jun 15; 75(12):2541-52. Wettersten HI, Hakimi AA, Morin D, Bianchi C, Johnstone ME, Donohoe DR, Trott JF, Aboud OA, Stirdivant S, Neri B, Wolfert R, Stewart B, Perego R, Hsieh JJ, Weiss RH. PMID: 25952651.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    39. Exercise-associated hyponatremia with exertional rhabdomyolysis: importance of proper treatment. Clin Nephrol. 2015 Apr; 83(4):235-42. Hoffman MD, Stuempfle KJ, Sullivan K, Weiss RH. PMID: 24931911.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. PPARa inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth. Am J Physiol Cell Physiol. 2015 Jun 01; 308(11):C890-8. Abu Aboud O, Donohoe D, Bultman S, Fitch M, Riiff T, Hellerstein M, Weiss RH. PMID: 25810260.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    41. Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth. PLoS One. 2014; 9(12):e113867. Wettersten HI, Landesman Y, Friedlander S, Shacham S, Kauffman M, Weiss RH. PMID: 25461627.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    42. Biological evaluation of a novel sorafenib analogue, t-CUPM. Cancer Chemother Pharmacol. 2015 Jan; 75(1):161-71. Wecksler AT, Hwang SH, Liu JY, Wettersten HI, Morisseau C, Wu J, Weiss RH, Hammock BD. PMID: 25413440.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    43. Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK4 levels. Am J Physiol Renal Physiol. 2014 Dec 01; 307(11):F1179-86. Tan M, Wettersten HI, Chu K, Huso DL, Watnick T, Friedlander S, Landesman Y, Weiss RH. PMID: 25234309.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    44. On-chip detection of a single nucleotide polymorphism without polymerase amplification. Nano Res. 2014 Sep 01; 7(9):1302-1310. Han J, Tan M, Sudheendra L, Weiss RH, Kennedy IM. PMID: 25580203.
      View in: PubMed   Mentions:
    45. Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):11127-32. Zhang G, Panigrahy D, Hwang SH, Yang J, Mahakian LM, Wettersten HI, Liu JY, Wang Y, Ingham ES, Tam S, Kieran MW, Weiss RH, Ferrara KW, Hammock BD. PMID: 25024195.
      View in: PubMed   Mentions: 34     Fields:    Translation:Animals
    46. Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):E3062-71. Gupta R, Dong Y, Solomon PD, Wettersten HI, Cheng CJ, Min JN, Henson J, Dogra SK, Hwang SH, Hammock BD, Zhu LJ, Reddel RR, Saltzman WM, Weiss RH, Chang S, Green MR, Wajapeyee N. PMID: 25024194.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    47. Symptomatic hypotonic hyponatremia presenting at high altitude. Wilderness Environ Med. 2014 Sep; 25(3):362-3. Hoffman MD, Weiss RH. PMID: 24768570.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMB. Anticancer Drugs. 2014 Apr; 25(4):433-46. Wecksler AT, Hwang SH, Wettersten HI, Gilda JE, Patton A, Leon LJ, Carraway KL, Gomes AV, Baar K, Weiss RH, Hammock BD. PMID: 24525589.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    49. Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment. PLoS One. 2014; 9(1):e86223. Kim K, Mall C, Taylor SL, Hitchcock S, Zhang C, Wettersten HI, Jones AD, Chapman A, Weiss RH. PMID: 24475090.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    50. Biomarkers in IgA nephropathy. Biomark Med. 2014; 8(10):1263-77. Hwang VJ, Ulu A, van Hoorebeke J, Weiss RH. PMID: 25525986.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    51. Metabolomic profiling of tumor-bearing mice. Methods Enzymol. 2014; 543:275-96. Wettersten HI, Ganti S, Weiss RH. PMID: 24924138.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    52. Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids. PLoS One. 2013; 8(10):e76575. Nording ML, Yang J, Georgi K, Hegedus Karbowski C, German JB, Weiss RH, Hogg RJ, Trygg J, Hammock BD, Zivkovic AM. PMID: 24204640.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    53. Anti-inflammatory effects of ?-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension. J Cardiovasc Pharmacol. 2013 Sep; 62(3):285-97. Ulu A, Harris TR, Morisseau C, Miyabe C, Inoue H, Schuster G, Dong H, Iosif AM, Liu JY, Weiss RH, Chiamvimonvat N, Imig JD, Hammock BD. PMID: 23676336.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    54. Inhibition of PPARa induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells. PLoS One. 2013; 8(8):e71115. Abu Aboud O, Wettersten HI, Weiss RH. PMID: 23951092.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    55. Stability of miRNA in human urine supports its biomarker potential. Biomark Med. 2013 Aug; 7(4):623-31. Mall C, Rocke DM, Durbin-Johnson B, Weiss RH. PMID: 23905899.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    56. Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer. Future Med Chem. 2013 Jun; 5(9):991-4. Liu R, Wettersten HI, Park SH, Weiss RH. PMID: 23734682.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A. 2013 Apr 16; 110(16):6530-5. Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S, Hwang SH, Ingham ES, Kieran MW, Weiss RH, Ferrara KW, Hammock BD. PMID: 23553837.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansAnimalsCells
    58. Potential biofluid markers and treatment targets for renal cell carcinoma. Nat Rev Urol. 2013 Jun; 10(6):336-44. Wettersten HI, Weiss RH. PMID: 23545813.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    59. From bead to flask: Synthesis of a complex ß-amido-amide for probe-development studies. Beilstein J Org Chem. 2013; 9:260-4. Martin KS, Soldi C, Candee KN, Wettersten HI, Weiss RH, Shaw JT. PMID: 23400429.
      View in: PubMed   Mentions:
    60. A novel p21 attenuator which is structurally related to sorafenib. Cancer Biol Ther. 2013 Mar; 14(3):278-85. Wettersten HI, Hee Hwang S, Li C, Shiu EY, Wecksler AT, Hammock BD, Weiss RH. PMID: 23298903.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    61. Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets. Organogenesis. 2013 Jan-Mar; 9(1):11-8. Wettersten HI, Weiss RH. PMID: 23538740.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    62. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics. 2012 Dec; 8(6):1102-1113. Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O'Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C, Hammock BD. PMID: 23833568.
      View in: PubMed   Mentions: 32     Fields:    
    63. New opportunities from the cancer metabolome. Clin Chem. 2013 Jan; 59(1):138-46. Aboud OA, Weiss RH. PMID: 23150057.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    64. CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth. J Urol. 2013 Jun; 189(6):2317-26. Inoue H, Kauffman M, Shacham S, Landesman Y, Yang J, Evans CP, Weiss RH. PMID: 23079374.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    65. Urine dipstick analysis for identification of runners susceptible to acute kidney injury following an ultramarathon. J Sports Sci. 2013; 31(1):20-31. Hoffman MD, Stuempfle KJ, Fogard K, Hew-Butler T, Winger J, Weiss RH. PMID: 23035796.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    66. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res. 2012 Jul 15; 72(14):3471-9. Ganti S, Taylor SL, Abu Aboud O, Yang J, Evans C, Osier MV, Alexander DC, Kim K, Weiss RH. PMID: 22628425.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    67. Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy. Cancer Biol Ther. 2011 Nov 01; 12(9):827-36. Inoue H, Hwang SH, Wecksler AT, Hammock BD, Weiss RH. PMID: 21878748.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    68. Metabolomics in the study of kidney diseases. Nat Rev Nephrol. 2011 Oct 25; 8(1):22-33. Weiss RH, Kim K. PMID: 22025087.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    69. Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer. 2012 Jun 15; 130(12):2791-800. Ganti S, Taylor SL, Kim K, Hoppel CL, Guo L, Yang J, Evans C, Weiss RH. PMID: 21732340.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    70. Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol. 2011 Sep-Oct; 29(5):551-7. Ganti S, Weiss RH. PMID: 21930086.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    71. Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers. J Virol. 2011 Sep; 85(18):9646-50. Buzon MJ, Seiss K, Weiss R, Brass AL, Rosenberg ES, Pereyra F, Yu XG, Lichterfeld M. PMID: 21734042.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    72. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest. 2011 Apr; 121(4):1549-60. Chen H, Li C, Huang J, Cung T, Seiss K, Beamon J, Carrington MF, Porter LC, Burke PS, Yang Y, Ryan BJ, Liu R, Weiss RH, Pereyra F, Cress WD, Brass AL, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. PMID: 21403397.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    73. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS. 2011 May; 15(5):293-303. Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH. PMID: 21348635.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    74. Pharmacological inhibition of cyclin dependent kinases causes p53 dependent apoptosis in renal cell carcinoma. J Urol. 2010 Nov; 184(5):2143-9. Ishimaru T, Lau J, Jackson AL, Modiano JF, Weiss RH. PMID: 20850841.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    75. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol. 2010 Apr; 298(4):F909-22. Taylor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH. PMID: 20130118.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    76. Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo. Mol Cancer Ther. 2009 Aug; 8(8):2193-203. Liu JY, Park SH, Morisseau C, Hwang SH, Hammock BD, Weiss RH. PMID: 19671760.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    77. Grade-dependent proteomics characterization of kidney cancer. Mol Cell Proteomics. 2009 May; 8(5):971-85. Perroud B, Ishimaru T, Borowsky AD, Weiss RH. PMID: 19164279.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    78. High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers. Cancer Biol Ther. 2008 Dec; 7(12):2015-22. Park SH, Wang X, Liu R, Lam KS, Weiss RH. PMID: 18981726.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    79. Disparate effects of roscovitine on renal tubular epithelial cell apoptosis and senescence: implications for autosomal dominant polycystic kidney disease. Am J Nephrol. 2009; 29(6):509-15. Park JY, Park SH, Weiss RH. PMID: 19066425.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    80. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics. 2009 Mar; 8(3):558-70. Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, Weiss RH. PMID: 19008263.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    81. Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model. J Cardiovasc Pharmacol. 2008 Oct; 52(4):314-23. Ulu A, Davis BB, Tsai HJ, Kim IH, Morisseau C, Inceoglu B, Fiehn O, Hammock BD, Weiss RH. PMID: 18791465.
      View in: PubMed   Mentions: 52     Fields:    Translation:AnimalsCells
    82. Antisense attenuation of p21 sensitizes kidney cancer to apoptosis in response to conventional DNA damaging chemotherapy associated with enhancement of phospho-p53. J Urol. 2008 Jul; 180(1):352-60. Park SH, Park JY, Weiss RH. PMID: 18499163.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    83. Rapid and quantitative DNA analysis of genetic mutations for polycystic kidney disease (PKD) using magnetic/luminescent nanoparticles. Anal Bioanal Chem. 2008 Apr; 390(7):1829-35. Son A, Dhirapong A, Dosev DK, Kennedy IM, Weiss RH, Hristova KR. PMID: 18256809.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    84. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrol. 2007 Aug 22; 8:12. Park JY, Schutzer WE, Lindsley JN, Bagby SP, Oyama TT, Anderson S, Weiss RH. PMID: 17714589.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    85. Targeting the PI3K-Akt pathway in kidney cancer. Expert Rev Anticancer Ther. 2007 Jun; 7(6):863-70. Park JY, Lin PY, Weiss RH. PMID: 17555396.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    86. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance. Mol Cancer. 2007 Feb 14; 6:16. Lin PY, Fosmire SP, Park SH, Park JY, Baksh S, Modiano JF, Weiss RH. PMID: 17300726.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    87. A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem. 2007 Apr 15; 363(2):185-95. Kind T, Tolstikov V, Fiehn O, Weiss RH. PMID: 17316536.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    88. p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. J Urol. 2007 Jan; 177(1):63-8; discussion 68-9. Weiss RH, Borowsky AD, Seligson D, Lin PY, Dillard-Telm L, Belldegrun AS, Figlin RA, Pantuck AD. PMID: 17162001.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    89. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer. 2006 Nov 24; 5:64. Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH. PMID: 17123452.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    90. Kidney cancer: identification of novel targets for therapy. Kidney Int. 2006 Jan; 69(2):224-32. Weiss RH, Lin PY. PMID: 16408110.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimals
    91. Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition. J Pharmacol Exp Ther. 2006 Feb; 316(2):815-21. Davis BB, Morisseau C, Newman JW, Pedersen TL, Hammock BD, Weiss RH. PMID: 16221742.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    92. TNF-alpha-mediated apoptosis in vascular smooth muscle cells requires p73. Am J Physiol Cell Physiol. 2005 Jul; 289(1):C199-206. Tang V, Dhirapong A, Yabes AP, Weiss RH. PMID: 15716325.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    93. Exogenous attenuation of p21(Waf1/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1. J Am Soc Nephrol. 2004 Mar; 15(3):575-84. Fan YP, Weiss RH. PMID: 14978159.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    94. Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells. Cell Signal. 2004 Feb; 16(2):263-9. Dong Y, Chi SL, Borowsky AD, Fan Y, Weiss RH. PMID: 14636896.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    95. Vascular localization of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol. 2004 Apr; 286(4):F720-6. Yu Z, Davis BB, Morisseau C, Hammock BD, Olson JL, Kroetz DL, Weiss RH. PMID: 14665429.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    96. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell. 2003 Dec; 4(6):425-9. Weiss RH. PMID: 14706334.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    97. An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol Cancer Ther. 2003 Aug; 2(8):773-82. Fan Y, Borowsky AD, Weiss RH. PMID: 12939467.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    98. BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1. Am J Physiol Endocrinol Metab. 2003 May; 284(5):E972-9. Wong GA, Tang V, El-Sabeawy F, Weiss RH. PMID: 12527559.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    99. Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1). Cancer Lett. 2003 Jan 10; 189(1):39-48. Weiss RH, Marshall D, Howard L, Corbacho AM, Cheung AT, Sawai ET. PMID: 12445676.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    100. Overexpression of p73 causes apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2003 Jan; 284(1):C16-23. Davis BB, Dong Y, Weiss RH. PMID: 12388104.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    101. Attenuation of matrix protein secretion by antisense oligodeoxynucleotides to the cyclin kinase inhibitor p21(Waf1/Cip1). Atherosclerosis. 2002 Mar; 161(1):105-12. Weiss RH, Randour CJ. PMID: 11882322.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    102. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):2222-7. Davis BB, Thompson DA, Howard LL, Morisseau C, Hammock BD, Weiss RH. PMID: 11842228.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    103. Molecular genetics in renal medicine: what can we hope to achieve? Nephrol Dial Transplant. 2002; 17 Suppl 3:5-11. Nordfors L, Stenvinkel P, Marchlewska A, Weiss R, Heimbürger O, Bergström J, Lindholm B, Schalling M. PMID: 11912292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque. Cell Signal. 2001 Oct; 13(10):727-33. Weiss RH, Howard LL. PMID: 11602183.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    105. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27. Am J Physiol Endocrinol Metab. 2001 Aug; 281(2):E207-16. Hupfeld CJ, Weiss RH. PMID: 11440895.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    106. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells. Cell Signal. 2000 Jun; 12(6):413-8. Weiss RH, Randour CJ. PMID: 10889470.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    107. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem. 2000 Apr 07; 275(14):10285-90. Weiss RH, Joo A, Randour C. PMID: 10744715.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    108. Short-term pravastatin mediates growth inhibition and apoptosis, independently of Ras, via the signaling proteins p27Kip1 and P13 kinase. J Am Soc Nephrol. 1999 Sep; 10(9):1880-90. Weiss RH, Ramirez A, Joo A. PMID: 10477139.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    109. TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. Nephrol Dial Transplant. 1998 Nov; 13(11):2804-13. Weiss RH, Ramirez A. PMID: 9829482.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    110. Pravastatin and cyclosporine inhibit platelet-derived growth factor-stimulated vascular smooth muscle cell mitogenesis: an investigation of mechanisms. Transplant Proc. 1998 Jun; 30(4):998-9. Katznelson S, Ramirez A, Perez R, Weiss R. PMID: 9636403.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    111. MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells. Am J Physiol. 1998 06; 274(6):C1521-9. Weiss RH, Maga EA, Ramirez A. PMID: 9696694.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    112. G protein-coupled receptor signalling in the kidney. Cell Signal. 1998 May; 10(5):313-20. Weiss RH. PMID: 9692674.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    113. Divergence in the G-protein-coupled receptor mitogenic signalling pathway at the level of Raf kinase. Cell Signal. 1997 Sep; 9(6):439-45. Apostolidis A, Weiss RH. PMID: 9376225.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    114. HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism. J Am Soc Nephrol. 1997 Aug; 8(8):1247-56. Neverov NI, Kaysen GA, Nuccitelli R, Weiss RH. PMID: 9259351.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    115. Mitogenic inhibition by phorbol esters is associated with decreased phosphatidylinositol-3 kinase activation. Am J Physiol. 1996 Feb; 270(2 Pt 1):C619-27. Weiss RH, Yabes AP. PMID: 8779927.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    116. TGF-beta and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways. Kidney Int. 1995 Sep; 48(3):738-44. Weiss RH, Yabes AP, Sinaee R. PMID: 7474659.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    117. Dissociation of phosphatidylinositol-3 kinase activity and mitogenic inhibition in vascular smooth muscle cells. Cell Signal. 1995 Feb; 7(2):113-22. Weiss RH, Apostolidis A. PMID: 7794683.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    118. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol. 1993 Nov; 123(3):741-7. Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE. PMID: 8227136.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    119. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem. 1993 Mar 15; 268(8):5724-7. Weiss RH, Maduri M. PMID: 8449935.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    120. Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol. 1993 Mar; 264(3 Pt 2):F441-7. Sun X, Martin V, Weiss RH, Kaysen GA. PMID: 7681261.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    121. Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells. J Biol Chem. 1992 Mar 15; 267(8):5608-13. Weiss RH, Nuccitelli R. PMID: 1544934.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    122. Dissociation between activation of growth-related genes and mitogenic responses of neonatal vascular smooth muscle cells. Biochem Biophys Res Commun. 1991 Dec 16; 181(2):617-22. Weiss RH, Ives HE. PMID: 1755845.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    123. Sphingosine reverses growth inhibition caused by activation of protein kinase C in vascular smooth muscle cells. J Cell Physiol. 1991 Nov; 149(2):307-12. Weiss RH, Huang CL, Ives HE. PMID: 1748721.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells